Last updated on June 2012

Study Evaluating The Safety Of Subcutaneous Methylnaltrexone In Treatment Of Opioid-Induced Constipation


Brief description of study

This is an open-label, multicenter extension of study 3200K1-4000-WW that will evaluate the safety of methylnaltrexone. This drug will be administered by subcutaneous injection and will be tested in late stage, advanced illness patients who have constipation caused by opioid pain relievers. This study will last 3 months.

Clinical Study Identifier: NCT00672139

Contact Investigators or Research Sites near you

Start Over

Dave Mathews

Salix Investigational Site
American Fork, UT United States
1.1miles
  Connect »

Dave Mathews

Salix Investigational Site
Orem, UT United States
7.66miles
  Connect »